Bone And Joint Health Supplements Market Size, Share | Report 2022-2030
The global bone and joint health supplements market was valued at USD 2.11 billion in 2021 and it is predicted to surpass around USD 3.98 billion by 2030 with a CAGR of 7.31% from 2022 to 2030.
Report Highlights
Increasing prevalence of orthopedic disorders among the geriatric and adult population is one of the major factors driving the market. According to the CDC, around 58.5 million people are diagnosed with arthritis and it is more common in women as compared to men. Also, the increasing burden of arthritis is anticipated to drive the industry during the forecast period. As per the CDC, around 78.4 million adults aged 18 years and above are anticipated to be diagnosed with arthritis. Moreover, the rising geriatric population across the globe is fueling industry growth as the prevalence of orthopedic disorders increases with age. Around 49.6% of people aged above 65 years are diagnosed with arthritis.
Furthermore, the rising health consciousness, increasing consumer interest in active living, and rising disposable income are among the key factors driving the industry. In addition, increasing awareness regarding micronutrient deficiencies, increasing access to supplements, availability of multiple products, and the increasing number of distribution channels are supporting the growth.
Moreover, the increasing focus of key companies on various strategies to meet consumer demand is impelling market growth. For instance, in March 2022, Bioiberica entered into a partnership with ByHealth to develop a product for joint health brand “Highflex” in the China market. Furthermore, the manufacturers are developing new supplements in various formulations to attract the consumer base, thereby positively impacting the industry's growth. For instance, in February 2022, Gadot Biochemical Industries launched ‘Cal2Mag’, a new mineral blend combining calcium and magnesium, to specifically target bone health.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 2.11 billion |
| Revenue Forecast by 2030 | USD 3.98 billion |
| Growth rate from 2022 to 2030 | CAGR of 7.31% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Product, formulation, consumer group, sales channel, region |
| Companies Covered |
Herbalife International of America, Inc.; GNC Holdings, Inc.; Nature’s Bounty Co.; Bayer AG; BY-HEALTH Co., Ltd.; Amway; Basf SE; Reckitt Benckiser; Vita Life Sciences Ltd.; Glanbia Plc; Now Foods; Pfizer |
Product Insights
The vitamins segment dominated the market in 2021 with a share of over 30.03%. This can be attributed to the growing adoption of healthy lifestyles, increasing life expectancy, and rising focus on active lifestyles. Also, the increasing consumption of vitamin D supplements to reduce the risk of bone fracture is impelling market growth. Also, vitamin K is linked to bone density and subsequently is found to be effective for bone health. It is consumed by people suffering from osteoporosis to reduce the risk of fracture, which is expected to drive the segment over the forecast period.
The minerals segment is expected to grow at a lucrative rate due to the growing adoption of mineral supplements to manage conditions such as osteoporosis and osteoarthritis. The growing rate of osteoporosis among the women and geriatric population has raised the demand for calcium supplements. Furthermore, the increasing focus of the companies on the development of bone & joint health supplements to treat joint health is expected to drive the market over the forecast period. For instance, in May 2022, Vaneeghen introduced FruiteX-B, a mineral complex specifically for joint health, in the European market.
Formulation Insights
The capsules segment held the largest revenue share of over 30.16% in 2021. The availability of product types in various forms of encapsulations is responsible for an increase in the bioavailability of active ingredients. Multilayered or multi-membrane encapsulations, extended-release capsules for vitamins and minerals, and omega-3 fatty acids are some of the products currently available in capsule formulations, which have been responsible for the growth of the industry.
The powder formulations segment is expected to grow at the fastest rate over the forecast period. Powder formulations have captured the market and have been preferentially used in comparison to soft chews and soft gels due to their ease of consumption. Growing demand for powdered vitamin supplements has led to the high growth of this segment.
Consumer Group Insights
The geriatric population segment held the largest revenue share of over 32.4% in 2021. The geriatric population is the major consumer of bone and joint health supplements as the prevalence of bone disorders rise with aging. Osteoporosis is the most common disorder in elders. As per a study, the prevalence of osteoporosis in India was 36.1% among the geriatric population in 2021. Also, about 1.5 million fractures occur due to osteoporosis each year in the U.S. Therefore, increased demand is being witnessed to prevent fractures and maintain bone health.
The adult segment is expected to grow at the fastest rate during the forecast period owing to increasing awareness regarding nutritional supplements. With the shifting trend toward a healthy and active lifestyle, adults are consuming various supplements to maintain their bone health. As per the CRN survey, around 18% of people aged 18 to 34 years and 19% of people aged 35-54 years consume bone health dietary supplements. Furthermore, this number is expected to rise due to the increasing adult population suffering from arthritis. As per the CDC, around 57.3% of the adult population in the U.S. suffer from arthritis.
Sales Channel Insights
The bricks and mortar segment held the largest revenue share of over 65.7% in 2021. The rising number of retail stores selling supplements for bone and joint health with a wide variety of product types of different brands is one of the key factors responsible for the growth of the segment. In, addition, the companies are investing in the opening of stores to reach a larger population base and meet the consumer demand, which is further contributing to the industry growth.
The e-commerce segment is expected to witness the fastest growth during the forecast period. The online sales channel has witnessed substantial growth during COVID-19 and the channel emerged as a strategy to increase geographical reach. The market players are collaborating with e-commerce platforms to make their product types available online, which is positively impacting the growth of the market. Moreover, the shifting consumer preference toward online shopping is expected to drive the market over the forecast period. As per the report by Mintel, 50% of consumers prefer online shopping for mineral and vitamin supplements.
Regional Insights
North America accounted for the largest revenue share of over 35.42% in 2021. The increasing geriatric population and rising number of people suffering from joint pain are some of the factors driving the market in the region. As per the CDC, nearly 14.6 million people are diagnosed with severe joint pain. Moreover, the increasing prevalence of arthritis is fueling the industry's growth. In Canada, approximately 6 million people are diagnosed with arthritis. Furthermore, the increasing awareness regarding overall health among the population is impelling growth. As per the survey conducted by NMI in the U.S., around 37% of supplement consumers are likely to use bone and joint health supplements to support bone health. Also, the high prevalence of micronutrient deficiencies among adults is boosting the demand for bone and joint health supplements in the region.
The Asia Pacific is anticipated to grow at the fastest rate over the forecast period due to growing awareness regarding health and well-being coupled with nutritional deficiencies. The increasing prevalence of vitamin D deficiency and osteoporosis has raised the demand for various supplements supporting bone and joint health. Furthermore, with increasing disposable income, consumers are willing to pay more for supplement product types to maintain health, thereby positively impacting the market growth. In addition, various strategies adopted by companies to strengthen the industry growth in the APAC region are boosting regional growth.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Bone And Joint Health Supplements Market
5.1. COVID-19 Landscape: Bone And Joint Health Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Bone And Joint Health Supplements Market, By Product
8.1. Bone And Joint Health Supplements Market, by Product, 2022-2030
8.1.1. Vitamins
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Minerals
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Collagen
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Omega-3
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Glucosamine
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Bone And Joint Health Supplements Market, By Formulation
9.1. Bone And Joint Health Supplements Market, by Formulation, 2022-2030
9.1.1. Capsules
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Tablets
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Powders
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Softgels
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Bone And Joint Health Supplements Market, By Consumer Group
10.1. Bone And Joint Health Supplements Market, by Consumer Group, 2022-2030
10.1.1. Infants
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Children
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Adults
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Pregnant Women
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Geriatric Population
10.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Bone And Joint Health Supplements Market, By Sales Channel
11.1. Bone And Joint Health Supplements Market, by Sales Channel, 2022-2030
11.1.1. Bricks And Mortar
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. E-commerce
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Bone And Joint Health Supplements Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.1.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.1.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.2.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.2.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.3.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.3.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.4.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.4.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.5.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.5.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Formulation (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Sales Channel (2017-2030)
Chapter 13. Company Profiles
13.1. Herbalife International of America, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. GNC Holdings, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Nature’s Bounty Co.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Bayer AG
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. BY-HEALTH Co., Ltd.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Amway (US)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Basf SE
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Reckitt Benckiser (UK)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Vita Life Sciences Ltd.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Glanbia Plc
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers